Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Selin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS Agreement, drawing lessons from Türkiye’s long-standing pharmaceutical patent jurisprudence
Baran Güney and Elif Melis Özsoy of Gün + Partners examine a ruling on whether using competitors’ trademarks in Google Ads constitutes infringement, emphasising the burden of proof and arguing for assessment under unfair competition law
A Turkish case highlights the importance of Article 138(3) when patent claims are amended during an invalidation action, say Selin Sinem Erciyas, Aysel Korkmaz Yatkın, and Bengü Şen Gürakan of Gün + Partners
